Quarterly ResultMay 7, 2026, 06:37 AM
Enovis Q1 Net Sales $589.15M; Net Loss $(8.76)M, EPS $(0.15)
AI Summary
Enovis Corporation reported a significant improvement in its financial performance for the three months ended April 3, 2026. Net sales increased to $589.15 million, while the net loss attributable to the company substantially narrowed to $(8.76) million, or $(0.15) per diluted share, compared to a loss of $(55.97) million, or $(0.98) per share, in the prior year. The company also generated positive net cash from operating activities, totaling $23.95 million, a notable turnaround from a cash outflow in the previous year, reflecting stronger operational efficiency.
Key Highlights
- Net sales increased to $589.15 million for Q1 2026, up from $558.83 million in Q1 2025.
- Net loss attributable to Enovis Corporation significantly reduced to $(8.76) million from $(55.97) million year-over-year.
- Diluted net loss per share improved to $(0.15) for Q1 2026, compared to $(0.98) in Q1 2025.
- Operating income was $6.53 million, a significant improvement from an operating loss of $(46.77) million year-over-year.
- Net cash provided by operating activities was $23.95 million, a turnaround from net cash used of $(1.60) million year-over-year.
- Reconstructive segment net sales grew to $317.13 million from $286.25 million year-over-year.
- Prevention & Recovery segment net sales were $272.02 million, a slight decrease from $272.58 million year-over-year.
- Total debt increased to $1.33 billion as of April 3, 2026, from $1.30 billion at December 31, 2025.
Price Impact
More from ENOV